Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:2339-2347

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thiagarajan, P.
Right arrow Articles by Benedict, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thiagarajan, P.
Right arrow Articles by Benedict, C. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*HEPARIN

(Circulation. 1997;96:2339-2347.)
© 1997 American Heart Association, Inc.


Articles

Inhibition of Arterial Thrombosis by Recombinant Annexin V in a Rabbit Carotid Artery Injury Model

Perumal Thiagarajan, MD; ; Claude R. Benedict, MD, DPhil

From the Divisions of Hematology and Cardiology, Department of Internal Medicine, University of Texas Health Science Center, Houston.

Correspondence to Claude R. Benedict, MD, DPhil, Department of Internal Medicine, Division of Cardiology, MSB 6.039, University of Texas Medical School, 6431 Fannin St, Houston, TX 77030.

Background The procoagulant effect of anionic phospholipid may play a major role in the development of arterial thrombosis.

Methods and Results Annexin V, a calcium-dependent anionic-phospholipid–binding protein, was expressed and isolated from Escherichia coli and its antithrombotic effect examined in a rabbit carotid artery thrombosis model. A partially occlusive thrombus was formed in the left carotid artery by application of electric current to produce an {approx}50% occlusion of the lumen. After the current was discontinued, flow ceased completely within 42±12 minutes (n=6) because of continuing platelet/fibrin thrombus formation. When annexin V was given at doses of 2.8 to 16.6 µg · kg-1 · min-1 for a period of 180 minutes, starting at the time the current was stopped, there was a dose-dependent inhibition of thrombus formation. At a dose of 5.6 µg · kg-1 · min-1, blood flow remained patent throughout the infusion and for an additional 60 minutes after the infusion was stopped. In addition, there was a decrease in thrombus weight (16±7.4 versus 2.0±1.0 g), 125I-fibrin deposition ({approx}45% reduction, P<.001), and 111In-labeled platelet accumulation ({approx}43% reduction, P<.001). Prior mixing of annexin V with phosphatidylserine micelles abolished the antithrombotic effect of annexin V, whereas mixing with phosphatidylcholine micelles had no effect. The antithrombotic effect of annexin V was not associated with bleeding tendency, as judged by the amount of blood absorbed in a gauze pad placed in a surgical incision extending to the muscle tissue and by the standard template bleeding time.

Conclusions These observations support a potentially important role for anionic phospholipid exposure in platelets in arterial thrombosis, and inhibition of this activity could be a novel target for therapy in coronary thrombosis and stroke and after angioplasty.


Key Words: annexins • thrombosis • phospholipids • hemodynamics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
N. D. Papamichael, E. M. Stathopoulou, V. D. Roussa, L. D. Tsironis, A. P. Kotsia, R.-M. Stanica, V. Moussis, V. Tsikaris, C. S. Katsouras, A. D. Tselepis, et al.
Effect of a Synthetic Peptide Corresponding to Residues 313 to 320 of the {alpha}IIb Subunit of the Human Platelet Integrin {alpha}IIb{beta}3 on Carotid Artery Thrombosis in Rabbits
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 634 - 640.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. K. Dasgupta, H. Abdel-Monem, P. Niravath, A. Le, R. V. Bellera, K. Langlois, S. Nagata, R. E. Rumbaut, and P. Thiagarajan
Lactadherin and clearance of platelet-derived microvesicles
Blood, February 5, 2009; 113(6): 1332 - 1339.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
J. Gralla, G. Schroth, L. Remonda, A. Fleischmann, J. Fandino, J. Slotboom, and C. Brekenfeld
A Dedicated Animal Model for Mechanical Thrombectomy in Acute Stroke
AJNR Am. J. Neuroradiol., June 1, 2006; 27(6): 1357 - 1361.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Mangin, C. L. Yap, C. Nonne, S. A. Sturgeon, I. Goncalves, Y. Yuan, S. M. Schoenwaelder, C. E. Wright, F. Lanza, and S. P. Jackson
Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcR{gamma} deficiency
Blood, June 1, 2006; 107(11): 4346 - 4353.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. del Conde, C. N. Shrimpton, P. Thiagarajan, and J. A. Lopez
Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation
Blood, September 1, 2005; 106(5): 1604 - 1611.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H.-H. Chen, C. P. Vicente, L. He, D. M. Tollefsen, and T.-C. Wun
Fusion proteins comprising annexin V and Kunitz protease inhibitors are highly potent thrombogenic site-directed anticoagulants
Blood, May 15, 2005; 105(10): 3902 - 3909.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. van Tits, J. de Graaf, H. Toenhake, W. van Heerde, and A. Stalenhoef
C-Reactive Protein and Annexin A5 Bind to Distinct Sites of Negatively Charged Phospholipids Present in Oxidized Low-Density Lipoprotein
Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 717 - 722.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Merten, C. Beythien, K. Gutensohn, P. Kuhnl, T. Meinertz, and P. Thiagarajan
Sulfatides Activate Platelets Through P-Selectin and Enhance Platelet and Platelet-Leukocyte Aggregation
Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 258 - 263.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Cederholm, E. Svenungsson, K. Jensen-Urstad, C. Trollmo, A.-K. Ulfgren, J. Swedenborg, G.-Z. Fei, and J. Frostegard
Decreased Binding of Annexin V to Endothelial Cells: A Potential Mechanism in Atherothrombosis of Patients With Systemic Lupus Erythematosus
Arterioscler Thromb Vasc Biol, January 1, 2005; 25(1): 198 - 203.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Mandinov, A. Mandinova, S. Kyurkchiev, D. Kyurkchiev, I. Kehayov, V. Kolev, R. Soldi, C. Bagala, E. D. de Muinck, V. Lindner, et al.
Copper chelation represses the vascular response to injury
PNAS, May 27, 2003; 100(11): 6700 - 6705.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. H. Lee, L. Bardossy, N. Peterson, and M. A. Blajchman
o-Raffinose cross-linked hemoglobin improves the hemostatic defect associated with anemia and thrombocytopenia in rabbits
Blood, November 15, 2000; 96(10): 3630 - 3636.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C S Jurgensen, G Levantino, G Houen, S Jacobsen, P Halberg, S Ullman, M A Khamashta, K Asmussen, P Oxholm, M. Jurgensen, et al.
Determination of autoantibodies to annexin XI in systemic autoimmune diseases
Lupus, September 1, 2000; 9(7): 515 - 520.
[Abstract] [PDF]


Home page
CirculationHome page
M. Merten, R. Pakala, P. Thiagarajan, and C. R. Benedict
Platelet Microparticles Promote Platelet Interaction With Subendothelial Matrix in a Glycoprotein IIb/IIIa–Dependent Mechanism
Circulation, May 18, 1999; 99(19): 2577 - 2582.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
X. Wang, M. A. Kaetzel, S. E. Yoo, P. S. Kim, and J. R. Dedman
Ligand-regulated secretion of recombinant annexin V from cultured thyroid epithelial cells
Am J Physiol Cell Physiol, June 1, 2002; 282(6): C1313 - C1321.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
H. Ishii, M. Yoshida, M. Hiraoka, K. A. Hajjar, A. Tanaka, Y. Yasukochi, and F. Numano
Recombinant Annexin II Modulates Impaired Fibrinolytic Activity In Vitro and in Rat Carotid Artery
Circ. Res., December 7, 2001; 89(12): 1240 - 1245.
[Abstract] [Full Text] [PDF]